DGICA logo

DONEGAL GROUP INC-CL A

DGICANASDAQ
πŸ† #2253 by market capEarnings Oct 28US Equity
$18.68β–² $0.01 (+0.05%)
Market closed Β· at close
1hβ€”
24hβ–² 0.1%
7dβ–Ό 4.8%
14dβ–Ό 3.3%
30dβ–Ό 2.4%
1yβ–² 7.2%
🏦Market Cap
$692M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-3.1%
Declining
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
6.7%
Moderate
βš–οΈP/S Ratio
0.8x
Cheap
Otter Score
53
Weak

Trading Snapshot

Day Range
$18.53 – $19.03
52-Week Range
$16.11 – $21.06
Volume
$3.25B
Avg Volume
$3.51B
Shares Outstanding
37.0M
Next Earnings
Oct 4, 2026

Fundamentals Snapshot

Annual Revenue
$978M
Last Q Revenue
$241M
P/E Ratio
10.4
P/S Ratio
0.8x
EPS (TTM)
$1.91
Dividend Yield
3.55%

Why Investors Own DGICA

  • βœ“High-growth profile β€” revenue up +47.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 44% gross margin and 15% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$978Mβ–² +52.9% YoY
Gross Margin (TTM)
44.4%β–² +3.4% YoY
Operating Income (TTM)
$238Mβ–² +52.9% YoY
Free Cash Flow (TTM)
$142Mβ–² +52.9% YoY

About DONEGAL GROUP INC-CL A

Donegal Group, Inc. is an insurance holding company, which engages in the provision of property and casualty insurance to businesses and individuals. It operates through the following segments: Investment Function, Personal Lines of Insurance, and Commercial Lines of Insurance. The Investment Function segment covers investment activities. The Personal Lines of Insurance segment consists of homeowners and private passenger automobile policies. The Commercial Lines of Insurance segment includes commercial automobile, commercial multi-peril, and workers compensation policies. The company was founded on August 26, 1986 and is headquartered in Marietta, PA.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
53/100

Analyst Price Target

β“˜
Average Target
$22.15
β–² +18.6% Upside
High Target$26.67
Low Target$19.77
Based on 14 analysts

Latest News & Updates